India
· Delayed Price · Currency is INR NSE:SUNPHARMA Statistics
Total Valuation
NSE:SUNPHARMA has a market cap or net worth of INR 4.16 trillion. The enterprise value is 3.99 trillion.
| Market Cap | 4.16T |
| Enterprise Value | 3.99T |
Important Dates
The next estimated earnings date is Thursday, May 22, 2025.
| Earnings Date | May 22, 2025 |
| Ex-Dividend Date | Feb 6, 2025 |
Share Statistics
NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.40B |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 12.01% |
| Owned by Institutions (%) | 28.47% |
| Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 36.36 and the forward PE ratio is 35.80. NSE:SUNPHARMA's PEG ratio is 2.46.
| PE Ratio | 36.36 |
| Forward PE | 35.80 |
| PS Ratio | 8.05 |
| PB Ratio | 6.01 |
| P/TBV Ratio | 8.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.46 |
Enterprise Valuation
| EV / Earnings | 34.89 |
| EV / Sales | 7.73 |
| EV / EBITDA | 27.02 |
| EV / EBIT | 32.53 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | n/a |
| Interest Coverage | 48.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.20% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 12.00M |
| Profits Per Employee | 2.66M |
| Employee Count | 43,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.09% in the last 52 weeks. The beta is 0.55, so NSE:SUNPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +8.09% |
| 50-Day Moving Average | 1,710.72 |
| 200-Day Moving Average | 1,752.48 |
| Relative Strength Index (RSI) | 54.96 |
| Average Volume (20 Days) | 2,204,488 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUNPHARMA had revenue of INR 516.03 billion and earned 114.34 billion in profits. Earnings per share was 47.71.
| Revenue | 516.03B |
| Gross Profit | 403.32B |
| Operating Income | 122.81B |
| Pretax Income | 132.97B |
| Net Income | 114.34B |
| EBITDA | 146.44B |
| EBIT | 122.81B |
| Earnings Per Share (EPS) | 47.71 |
Balance Sheet
The company has 201.22 billion in cash and 25.72 billion in debt, giving a net cash position of 175.50 billion or 73.15 per share.
| Cash & Cash Equivalents | 201.22B |
| Total Debt | 25.72B |
| Net Cash | 175.50B |
| Net Cash Per Share | 73.15 |
| Equity (Book Value) | 693.80B |
| Book Value Per Share | 288.72 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.16%, with operating and profit margins of 23.80% and 22.16%.
| Gross Margin | 78.16% |
| Operating Margin | 23.80% |
| Pretax Margin | 25.77% |
| Profit Margin | 22.16% |
| EBITDA Margin | 28.38% |
| EBIT Margin | 23.80% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 15.50, which amounts to a dividend yield of 0.89%.
| Dividend Per Share | 15.50 |
| Dividend Yield | 0.89% |
| Dividend Growth (YoY) | 24.00% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 0.15% |
| Shareholder Yield | 1.04% |
| Earnings Yield | 2.75% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |